An aggressive marketing campaign has made the EpiPen the go-to drug for treating anaphylaxis. Mark Zaleski/AP hide caption

toggle caption Mark Zaleski/AP

EpiPen Manufacturer Says It Will Help With Out-Of-Pocket Costs

  • Download
  • <iframe src="https://www.npr.org/player/embed/491232665/491311810" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tim Kilroy runs a business from his home in Arlington, Mass. His insurance company quit covering the long-acting Ritalin that helps him manage his ADHD. Ellen Webber for NPR hide caption

toggle caption Ellen Webber for NPR

Fight To Lower Drug Prices Forces Some To Switch Medication

  • Download
  • <iframe src="https://www.npr.org/player/embed/463809474/464266304" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Maria Fabrizio for NPR

Multiple Sclerosis Patients Stressed Out By Soaring Drug Costs

  • Download
  • <iframe src="https://www.npr.org/player/embed/408021704/409421455" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

New hepatitis C drugs can cost as much as $1,000 per pill. Katherine Streeter for NPR hide caption

toggle caption Katherine Streeter for NPR

Medicare Won't Always Pay For Boomers' Pricey Hepatitis C Drugs

  • Download
  • <iframe src="https://www.npr.org/player/embed/307747798/311760028" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript